AQR Capital Management LLC lowered its stake in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 83.4% during the fourth quarter, Holdings Channel reports. The firm owned 57,732 shares of the company’s stock after selling 290,493 shares during the period. AQR Capital Management LLC’s holdings in DENTSPLY SIRONA were worth $3,333,000 at the end of the most recent quarter.
Several other hedge funds also recently made changes to their positions in XRAY. Conning Inc. increased its stake in shares of DENTSPLY SIRONA by 2.7% in the third quarter. Conning Inc. now owns 5,384 shares of the company’s stock valued at $320,000 after buying an additional 140 shares during the period. Albert D Mason Inc. increased its stake in shares of DENTSPLY SIRONA by 77.8% in the third quarter. Albert D Mason Inc. now owns 26,164 shares of the company’s stock valued at $1,555,000 after buying an additional 11,447 shares during the period. Harvey Investment Co. LLC increased its stake in shares of DENTSPLY SIRONA by 2.0% in the third quarter. Harvey Investment Co. LLC now owns 194,315 shares of the company’s stock valued at $11,548,000 after buying an additional 3,754 shares during the period. Benjamin F. Edwards & Company Inc. increased its stake in shares of DENTSPLY SIRONA by 3.2% in the third quarter. Benjamin F. Edwards & Company Inc. now owns 4,849 shares of the company’s stock valued at $288,000 after buying an additional 150 shares during the period. Finally, Grandfield & Dodd LLC increased its stake in shares of DENTSPLY SIRONA by 1.4% in the third quarter. Grandfield & Dodd LLC now owns 229,453 shares of the company’s stock valued at $13,636,000 after buying an additional 3,065 shares during the period. 94.32% of the stock is owned by institutional investors.
DENTSPLY SIRONA Inc (NASDAQ:XRAY) opened at 62.44 on Monday. DENTSPLY SIRONA Inc has a one year low of $55.00 and a one year high of $65.83. The company has a market capitalization of $14.34 billion, a PE ratio of 32.19 and a beta of 1.21. The company has a 50 day moving average price of $61.72 and a 200-day moving average price of $59.54.
DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Friday, February 17th. The company reported $0.67 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.65 by $0.02. The company earned $996.50 million during the quarter, compared to the consensus estimate of $1.02 billion. DENTSPLY SIRONA had a return on equity of 8.04% and a net margin of 11.15%. DENTSPLY SIRONA’s quarterly revenue was up 48.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.65 EPS. Analysts expect that DENTSPLY SIRONA Inc will post $2.85 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Thursday, April 13th. Investors of record on Friday, March 31st will be given a $0.0875 dividend. This is an increase from DENTSPLY SIRONA’s previous quarterly dividend of $0.08. The ex-dividend date of this dividend is Wednesday, March 29th. This represents a $0.35 dividend on an annualized basis and a yield of 0.56%. DENTSPLY SIRONA’s payout ratio is presently 15.98%.
Several brokerages have recently commented on XRAY. Barrington Research downgraded shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Tuesday, February 21st. Stifel Nicolaus upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating and increased their target price for the stock from $62.00 to $70.00 in a report on Monday, February 13th. Zacks Investment Research cut DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Monday, January 9th. Finally, Jefferies Group LLC cut their target price on DENTSPLY SIRONA from $70.00 to $68.00 and set a “buy” rating on the stock in a report on Monday, January 23rd. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have assigned a buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $67.75.
In other DENTSPLY SIRONA news, insider Bret W. Wise sold 146,900 shares of the business’s stock in a transaction that occurred on Wednesday, March 1st. The stock was sold at an average price of $64.17, for a total value of $9,426,573.00. Following the completion of the sale, the insider now owns 142,121 shares in the company, valued at $9,119,904.57. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Ulrich Michel sold 24,000 shares of the business’s stock in a transaction that occurred on Thursday, March 9th. The shares were sold at an average price of $62.84, for a total value of $1,508,160.00. Following the completion of the sale, the insider now owns 94,067 shares of the company’s stock, valued at approximately $5,911,170.28. The disclosure for this sale can be found here. Insiders sold a total of 265,554 shares of company stock valued at $16,726,342 in the last 90 days. 2.20% of the stock is currently owned by corporate insiders.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).
Receive News & Ratings for DENTSPLY SIRONA Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc and related companies with MarketBeat.com's FREE daily email newsletter.